Aytu Biopharma (AYTU) Receivables (2016 - 2025)
Historic Receivables for Aytu Biopharma (AYTU) over the last 11 years, with Q4 2025 value amounting to $30.9 million.
- Aytu Biopharma's Receivables rose 2172.97% to $30.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $30.9 million, marking a year-over-year increase of 2172.97%. This contributed to the annual value of $32.3 million for FY2025, which is 3747.77% up from last year.
- According to the latest figures from Q4 2025, Aytu Biopharma's Receivables is $30.9 million, which was up 2172.97% from $33.2 million recorded in Q3 2025.
- In the past 5 years, Aytu Biopharma's Receivables registered a high of $35.8 million during Q1 2025, and its lowest value of $21.6 million during Q3 2021.
- In the last 5 years, Aytu Biopharma's Receivables had a median value of $28.8 million in 2021 and averaged $28.3 million.
- Per our database at Business Quant, Aytu Biopharma's Receivables surged by 43871.83% in 2021 and then crashed by 2582.76% in 2024.
- Over the past 5 years, Aytu Biopharma's Receivables (Quarter) stood at $23.0 million in 2021, then rose by 11.13% to $25.5 million in 2022, then grew by 15.09% to $29.4 million in 2023, then dropped by 13.6% to $25.4 million in 2024, then rose by 21.73% to $30.9 million in 2025.
- Its Receivables was $30.9 million in Q4 2025, compared to $33.2 million in Q3 2025 and $31.2 million in Q2 2025.